Is AbbVie Inc. (ABBV) Stock Halal or Haram?

AbbVie Inc. (ABBV) - Halal (Shariah-Compliant)

AbbVie Inc. (ABBV) is classified as Halal (Shariah-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.

Business Activity Screen

Sector: Healthcare
Industry: Drug Manufacturers - General
Result: Pass
Reason: The sector "Healthcare" and industry "Drug Manufacturers - General" are not in the excluded categories.

Financial Ratios

Debt Ratio: Value: 17.5% | Threshold: 30% | Result: Pass
Cash & Interest-bearing Securities Ratio: Value: 1.6% | Threshold: 30% | Result: Pass
Non-Permissible Income Ratio: Value: 0.4% | Threshold: 5% | Result: Pass

Dividend Purification

Purification percentage: 0.43%.Based on the company's financial statements, approximately 0.43% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (0.43% of total income). Some scholars may differ on the exact calculation method.

About AbbVie Inc.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Business Activity

Pass

HealthcareDrug Manufacturers - General

The sector "Healthcare" and industry "Drug Manufacturers - General" are not in the excluded categories.

Business-activity data: inferred from the company description (lower confidence). How coverage works

Financial Ratios

Pass

Debt Ratio17.5% / 30%

Cash & Interest-bearing Securities Ratio1.6% / 30%

Non-Permissible Income Ratio0.4% / 5%

Denominator: Market Capitalization

Dividend Purification

0.43%

Based on the company's financial statements, approximately 0.43% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (0.43% of total income). Some scholars may differ on the exact calculation method.

Uses quarterly data

About AbbVie Inc.

United StatesNYSEHealthcare

Screened using AAOIFI Standard No. 21 on October 26, 2026. Financial ratios compared against market capitalization. Different methodologies may produce different results. Learn how we screen.

Screened using AAOIFI Shariah Standard No. 21 (3 ratios). Debt and interest-bearing deposits must each be under 30% of market capitalization, and non-permissible income under 5% of total income. This screening is for educational purposes only and does not constitute a fatwa or religious ruling. Results are based on publicly available financial data and automated analysis. Users should consult qualified Islamic scholars and financial advisors for personal investment decisions. Financial data may be delayed or incomplete. Past compliance does not guarantee future status.

Verdict history

Free with an account.

No verdict changes recorded since first screened on Mar 2, 2026. We started recording changes on Oct 19, 2026.

Dates are when Mizaan recorded the change. Tracked and watched stocks are re-checked weekly; other stocks are re-screened on demand.

Get More on the Mizaan App

Live charts, market cap, financials, AI business analysis, portfolio tracking, and compliance alerts — all on your phone.

Frequently Asked Questions

Screen Another Stock

Check if any stock or ETF is Shariah-compliant

View Portfolio

Monitor compliance across all your holdings

Screening

What Makes a Stock Halal?

Understand the business activity and financial ratio criteria used to screen stocks for Shariah compliance.

Purification

Dividend Purification Explained

Learn how to calculate and donate the non-permissible portion of your dividend income.

Frequently Asked Questions

Is AbbVie Inc. (ABBV) stock halal to invest in?

According to AAOIFI Shariah screening standards, AbbVie Inc. (ABBV) is currently classified as Halal (Shariah-Compliant). This is based on both business activity and financial ratio screening.

Does AbbVie Inc. have any interest income?

Identified interest income is 0.4% of AbbVie Inc.'s total income. AAOIFI standards require non-permissible income to be below 5%.

What guidelines are used to determine if ABBV stock is Shariah-compliant?

ABBV is screened using AAOIFI Standard No. 21, which involves two checks: business activity screening (ensuring the company's core business is permissible in Islam) and financial ratio screening (checking debt, interest income, and cash ratios against defined thresholds). AAOIFI is the most widely recognized standard for Islamic finance.

How often is AbbVie Inc. stock reviewed for Shariah compliance?

AbbVie Inc.'s compliance status is reviewed whenever new financial data becomes available, typically after quarterly or annual earnings reports. Market cap changes can also affect financial ratio screening results. Mizaan refreshes screening data periodically to reflect the latest filings.

How can I stay updated on AbbVie Inc.'s compliance status?

Watch ABBV free with a Mizaan account. Watched stocks are re-checked weekly, and any verdict change is dated in the verdict history on this page. Premium members also get an alert when it changes.

Are dividends from AbbVie Inc. stock considered halal?

Approximately 0.43% of dividend income from AbbVie Inc. comes from non-permissible sources such as interest income. Many investors purify that share by donating it to charity; scholars differ on the details, so check with one you trust.

Do I need to pay Zakat on my AbbVie Inc. shares?

Yes, Zakat is generally due on stock holdings. The calculation depends on your school of thought (madhab) and whether you hold shares for trading or long-term investment. Use Mizaan's Zakat calculator to compute your obligation based on your specific madhab and holding intent.

Salaam

AbbVie Inc.

Business Activity

Financial Ratios

Dividend Purification

About AbbVie Inc.

Verdict history

Get More on the Mizaan App

Frequently Asked Questions

Related Stocks

Screen Another Stock

View Portfolio

Related Articles

What Makes a Stock Halal?

Dividend Purification Explained

Frequently Asked Questions